Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05109117 · ClinicalTrials.gov registry record · NA
Clinical Study to Evaluate the Efficacy of an Over-the-counter (OTC) Sunscreen Lip Balm Product
A NA study, sponsored by HALEON.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT05109117 is a NA study that has completed, run by HALEON. The registered enrollment target is 39 participants.
The verdict
NCT05109117, a NA study, has completed, sponsored by HALEON.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the 8-hour moisturization efficacy of OTC sunscreen lip balm after a single treatment application.
Interventions
- DRUG CAP Unscented
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2021-12-07 |
| Est. Completion | 2021-12-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05109117
The ClinicalTrials.gov registry entry for NCT05109117 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HALEON, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CAP Unscented is the first listed.
NCT05109117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05109117 about?
NCT05109117 is a clinical study titled "Clinical Study to Evaluate the Efficacy of an Over-the-counter (OTC) Sunscreen Lip Balm Product". The purpose of this study is to evaluate the 8-hour moisturization efficacy of OTC sunscreen lip balm after a single treatment application.
What is the current status of trial NCT05109117?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2021-12-07. Estimated completion is 2021-12-17.
What interventions are being tested in trial NCT05109117?
The interventions under investigation include: CAP Unscented (DRUG).
Who is sponsoring clinical trial NCT05109117?
This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.